29608-05-7

Basic information

• Product Name: 4-PIPERIDIN-1-YLMETHYL-PHENYLAMINE
• Synonyms: TIMTEC-BB SBB007056;4-(PIPERIDIN-1-YLMETHYL)ANILINE;4-PIPERIDIN-1-YLMETHYL-PHENYLAMINE;4-(1-PIPERIDINYLMETHYL)ANILINE;AKOS MSC-0180;AKOS B014375;ART-CHEM-BB B016020;ART-CHEM-BB B014375
• CAS NO: 29608-05-7
• Molecular Formula: C₁₂H₁₈N₂
• Molecular Weight: 190.28
• EINECS: 1312995-182-4
• Product Categories: Amines and Anilines;Piperidine;Heterocyclic Compounds
• Mol File: 29608-05-7.mol
• Article Data: 24

Chemical Properties

• Melting Point: 90-93
• Boiling Point: 308.694 °C at 760 mmHg
• Flash Point: 126.388 °C
• Appearance: /
• Density: 1.068 g/cm³
• Vapor Pressure: 0.000794mmHg at 25°C
• Refractive Index: 1.555
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 9?+-.0.10(Predicted)
• Water Solubility: immiscible
• CAS DataBase Reference: 4-PIPERIDIN-1-YLMETHYL-PHENYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-PIPERIDIN-1-YLMETHYL-PHENYLAMINE(29608-05-7)
• EPA Substance Registry System: 4-PIPERIDIN-1-YLMETHYL-PHENYLAMINE(29608-05-7)

Safety Data

• Hazard Codes: C
• Statements: R36/37/38:
• Safety Statements: S26:; S36:
• Hazardous Substances Data: 29608-05-7(Hazardous Substances Data)

Usage

General Description

4-Piperidin-1-ylmethyl-phenylamine is a chemical compound that belongs to the class of organic compounds known as phenylpiperidines. This classification refers to compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. As a chemical, it may have various scientific and industrial applications. However, its specific properties such as reactivity, toxicity, and environmental impact would depend on its molecular structure and associated functional groups. It's relevant to note that this chemical does not appear to be widely researched or used, therefore, detailed information about it is limited. As with any chemical substances, proper safety measures should be taken when handling it.

InChI:InChI=1/C12H18N2/c1-2-4-11(5-3-1)10-14-12-6-8-13-9-7-12/h1-5,12-14H,6-10H2

Upstream product

• 59507-44-7 1-(4-nitrobenzyl)piperidine 
• 110-89-4 piperidine 
• 555-16-8 4-nitrobenzaldehdye 
• 100-14-1 4-nitrobenzyl chloride 
• 100-11-8 1-bromomethyl-4-nitro-benzene 

Downstream Products

• 108176-89-2 2-[(4-Piperidin-1-ylmethyl-phenylamino)-methyl]-isoindole-1,3-dione 
• 108176-83-6 3-<4-(N-piperidinomethyl)phenylaminomethyl>benzoxazolin-2-one 
• 108176-92-7 1,3-bis<4-(N-piperidinomethyl)phenylaminomethyl>benzimidazoline-2-thione 
• 108176-86-9 6-chloro-3-<4-(N-piperidinomethyl)phenylaminomethyl>benzoxazolin-2-one 
• 229003-39-8 7-phenyl-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide 
• 229003-49-0 7-(4-methylphenyl)-N-[4-(piperidinomethyl)phenyl]-3,4-dihydronaphthalene-2-carboxamide 
• 229005-30-5 N-[4-(1-piperidinylmethyl)phenyl]-6-(4-methylphenyl)-2H-1-benzopyran-3-carboxamide 
• 229004-30-2 7-(4-methylphenyl)-N-(4-(piperidinomethyl)phenyl)-2,3-dihydro-1-benzoxepine-4-carboxamide 
• 229004-26-6 2-[(4-methyl)phenyl]-N-{4-[(piperidin-1-yl)methyl]phenyl}-6,7-dihydro-5H-benzo[7]annulene-8-carboxamide 
• 263339-14-6 (Z)-6-nitro-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)methylene]-indolin-2-one 
• 689299-71-6 (E)-3-(4'-chloro-biphenyl-4-yl)-N-(4-piperidin-1-ylmethyl-phenyl)-acrylamide 
• 503183-23-1 4-[(4-(piperidin-1-ylmethyl)-phenyl)hydrazono]-4H-pyrazole-3,5-diamine 
• 422518-00-1 (Z)-1-acetyl-5-nitro-3-(phenyl(4-(piperidin-1-ylmethyl)phenylamino)methylene)-indolin-2-one 
• 307302-06-3 N-[4-(piperidinomethyl)phenyl]-7-phenyl-1,2,3,4-tetrahydronaphthalene-2-carboxamide 

Relevant articles and documents

Synthesis of the Kinase Inhibitors Nintedanib, Hesperadin, and Their Analogues Using the Eschenmoser Coupling Reaction

A novel synthetic approach involving an Eschenmoser coupling reaction of substituted 3-bromooxindoles (H, 6-Cl, 6-COOMe, 5-NO2) with two substituted thiobenzanilides in dimethylformamide or acetonitrile was used for the synthesis of eight kinase inhibitor

Beta-carboline derivative targeted to CDK and DNA and preparation method and medical application thereof

The invention discloses a beta-carboline derivative targeted to CDK and DNA and a preparation method and medical application thereof. The beta-carboline derivative has a structure shown in the general formula I in the description. The compound can be applied in combination with other antitumor drugs and can also be applied in combination with radiotherapy. The antitumor drugs or radiotherapy and the compound can be applied at the same time or at different times. The combined therapy can perform a synergistic effect, and thus the therapeutic effect can be easily improved.

Quinoline derivatives and their use

The invention discloses a quinoline derivative and a usage thereof, a compound with a structure as shown in a formula (I) and or a pharmaceutically acceptable salt of the compound. The compound or the pharmaceutically acceptable salt thereof disclosed by the invention can be applied to the field of preparation of drugs for preventing or treating tumors.